Transaction · 0001178913-26-002462

Burshtein Gregory

Burshtein Gregory, CR, D, reported a transaction classified as grant at Entera Bio Ltd. involving 87591.000000 shares for an estimated $0.00. Reported holdings after the transaction were 189033.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACR, D
ENTXEntera Bio Ltd.
Trade date
May 07, 2026
Filing date
May 08, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded87.5k$0.00 per share
Holdings after189kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ENTX price since this filing

Daily closing prices, with the filing date and available return windows
ENTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.7%1w ago1d ago +0.0%
Returns since7d30d +15.5%90d +156.4%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001178913-26-002462
Ordinary Shares, par value NIS 0.0000769 per share
Transaction date
May 07, 2026
Filed May 08, 2026, 08:26 PM · 1d delay
Shares
87,591 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
189,033 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief of R&D

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on…

Original filing · 0001178913-26-002462
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ENTX